Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$684M |
| 2 |
Amgen
AMGN
|
+$653M |
| 3 |
Salesforce
CRM
|
+$488M |
| 4 |
Eli Lilly
LLY
|
+$452M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$437M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Adobe
ADBE
|
+$815M |
| 2 |
NVIDIA
NVDA
|
+$685M |
| 3 |
TJX Companies
TJX
|
+$488M |
| 4 |
Starbucks
SBUX
|
+$373M |
| 5 |
CTLT
CATALENT, INC.
CTLT
|
+$361M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.92% |
| 2 | Healthcare | 18.9% |
| 3 | Consumer Discretionary | 9.38% |
| 4 | Financials | 9.11% |
| 5 | Industrials | 8.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2101
Sprinklr
CXM
$1.48B
| $376K | ﹤0.01% |
39,078
-622
| -2% | -$6.95K |
|
2102
BlueLinx
BXC
$465M
| $375K | ﹤0.01% |
4,037
-43
| -1% | -$4.56K |
|
2103
Protolabs
PRLB
$1.78B
| $375K | ﹤0.01% |
12,160
-132
| -1% | -$4.18K |
|
2104
Sphere Entertainment
SPHR
$5.06B
| $375K | ﹤0.01% |
10,692
-129
| -1% | -$5.02K |
|
2105
Amneal Pharmaceuticals
AMRX
$5.99B
| $374K | ﹤0.01% |
58,800
-570
| -1% | -$3.62K |
|
2106
Southside Bancshares
SBSI
$974M
| $374K | ﹤0.01% |
13,532
-147
| -1% | -$3.99K |
|
2107
Interface
TILE
$2B
| $373K | ﹤0.01% |
25,431
-292
| -1% | -$4.54K |
|
2108
United Natural Foods
UNFI
$3.07B
| $371K | ﹤0.01% |
28,316
-299
| -1% | -$3.36K |
|
2109
Fox Class A
FOXA
$24.2B
| $370K | ﹤0.01% |
10,778
-10,472
| -49% | -$342K |
|
|
SVC
2110
Service Properties Trust
SVC
$1.09B
| $370K | ﹤0.01% |
14,454
-167
| -1% | -$4.8K |
|
2111
AMERISAFE
AMSF
$573M
| $370K | ﹤0.01% |
8,435
-97
| -1% | -$4.45K |
|
2112
A10 Networks
ATEN
$2.25B
| $369K | ﹤0.01% |
26,678
-357
| -1% | -$5.09K |
|
2113
Cipher Digital
CIFR
$8.35B
| $368K | ﹤0.01% |
+88,700
| New | +$367K |
|
2114
Perella Weinberg Partners
PWP
$1.18B
| $366K | ﹤0.01% |
22,594
-68,121
| -75% | -$1.03M |
|
2115
Ocular Therapeutix
OCUL
$1.85B
| $366K | ﹤0.01% |
+53,500
| New | +$330K |
|
2116
Tilray
TLRY
$498M
| $365K | ﹤0.01% |
21,939
| – | – |
|
2117
Emcor
EME
$31.4B
| $365K | ﹤0.01% |
1,000
-36,611
| -97% | -$13.5M |
|
2118
TechTarget
TTGT
$323M
| $365K | ﹤0.01% |
11,734
-132
| -1% | -$3.92K |
|
2119
Liberty Live Group Series A
LLYVA
$9.15B
| $363K | ﹤0.01% |
9,700
-100
| -1% | -$3.74K |
|
2120
Cytek Biosciences
CTKB
$576M
| $361K | ﹤0.01% |
64,873
-601
| -0.9% | -$3.61K |
|
2121
PRA Group
PRAA
$688M
| $361K | ﹤0.01% |
18,385
-196
| -1% | -$4.51K |
|
2122
Sabre
SABR
$743M
| $358K | ﹤0.01% |
134,372
-1,944
| -1% | -$5.44K |
|
2123
Viridian Therapeutics
VRDN
$2.15B
| $357K | ﹤0.01% |
27,472
+14,051
| +105% | +$195K |
|
2124
BrightView Holdings
BV
$1.3B
| $357K | ﹤0.01% |
26,832
+10,497
| +64% | +$134K |
|
2125
UiPath
PATH
$6.32B
| $356K | ﹤0.01% |
28,137
-2,032
| -7% | -$35.1K |
|
Similar funds
Janus Henderson Group's Q2 2024 Portfolio in Review
As of Q2 2024, Janus Henderson Group held 2,619 positions worth $187B, up 1.9% from $183B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Janus Henderson Group's Q2 2024 filing shows 91 new, 630 increased, 1,758 reduced and 101 closed positions. Its largest new stake was UL Solutions: 2,328,210 shares worth $98.2M. The largest sale was Adobe, an estimated $815M.
By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 33% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Janus Henderson Group's largest Q2 2024 buy was UL Solutions: 2,328,210 shares worth $98.2M.
- Janus Henderson Group added most to Broadcom in Q2 2024, an estimated $684M increase.
- Janus Henderson Group's biggest Q2 2024 reduction was Adobe, cutting an estimated $815M.
- Janus Henderson Group fully exited Shockwave Medical, Inc. Common Stock in Q2 2024, selling an estimated $157M.
- Janus Henderson Group's ten largest holdings make up 32% of its $187B portfolio in Q2 2024.
- Janus Henderson Group opened 91 new positions and closed 101 in Q2 2024.
- Janus Henderson Group's portfolio value rose 1.9% quarter-over-quarter to $187B.
Based on Janus Henderson Group's 13F filing for Q2 2024, filed 14 Aug 2024.